Celsions Chief Medical Officer erectile dysfunction medicine.

D erectile dysfunction medicine ., Celsion’s Chief Medical Officer. Related StoriesOvarian cancer sufferers with a brief history of oral contraceptive make use of have better outcomesMeat-rich diet may increase kidney tumor riskCrucial change in one DNA base predisposes kids to aggressive form of malignancy We are pleased our study was among those that were accepted offering continued proof the medical community’s high interest level in ThermoDox, the progress of our clinical plan, and our concentrate on a cancer that’s very difficult to take care of, commented Michael H. Tardugno, Celsion’s President and CEO. Dr. Borys commented, Our Stage I/II trial combines ThermoDox with hyperthermia, supplying a unique approach to treating patients with hard loco-regional recurrence of breasts cancer at the chest wall.